Static IPs for Healthcare APIs That Need Encrypted Proxy Routing

If a healthcare app calls external APIs, static IPs are often part of the vendor review. EHR systems, lab platforms, pharmacy networks, and healthcare data vendors commonly ask customers to allowlist outbound IPs before API traffic is accepted.

That creates a problem for cloud apps. Heroku, serverless platforms, and many managed runtimes do not give each app a stable outbound IP by default. A static IP proxy fixes the allowlisting problem. The harder question is whether the proxy decrypts the traffic.

Shield Gives Healthcare Apps Static IPs Without Proxy-Level Payload Decryption

QuotaGuard Shield is built for the use case where a customer needs static IP routing and does not want customer payload contents decrypted at the proxy in ordinary operation.

Shield uses SSL passthrough. The customer’s application establishes a TLS connection to the destination API. Shield routes the encrypted traffic through static proxy IPs without receiving the customer’s private keys or decrypting the application payload.

That matters for healthcare teams because IP allowlisting and encrypted transmission are usually reviewed together. The vendor wants a stable source IP. The compliance team wants to know whether a third party can inspect PHI in transit.

Standard Proxies Can Create Healthcare Vendor Review Problems

Many managed proxy services use SSL termination. Your app connects to the proxy over TLS. The proxy decrypts the request, routes it, then re-encrypts it to the destination.

That model is normal for many API and automation workflows. It is often fine for non-regulated traffic.

For healthcare workloads involving ePHI, it can create a review problem. HIPAA-regulated customers generally need appropriate safeguards for ePHI in transit, and some security teams do not want patient data decrypted by proxy infrastructure outside their direct control.

That does not mean every proxy is automatically wrong for every healthcare workflow. It means the encryption model needs to match the customer’s regulatory, vendor, and risk requirements.

For HIPAA-regulated use, customers should confirm whether their vendor relationships require a BAA. QuotaGuard offers BAA review for approved Shield configurations after intake review and signed documentation. Start BAA Review →

Shield Preserves Encrypted Transmission While Providing Static Proxy IPs

QuotaGuard Shield gives the customer two static IPs for allowlisting while preserving encrypted transmission through the proxy layer.

In ordinary operation, Shield does not decrypt customer payload contents. QuotaGuard does not receive customer private keys or certificates required to decrypt customer application payloads.

The destination API sees traffic from the assigned QuotaGuard Shield IPs. The customer submits those IPs to the vendor’s allowlist. The customer’s application still controls its own TLS certificates, credentials, and endpoint security.

Shield Starts at $29 Per Month Before BAA Administration

QuotaGuard Shield starts at $29 per month for direct customers. Shield includes static IP routing, SSL passthrough, usage analytics, and proxy infrastructure for compliance-sensitive workloads.

BAA coverage is separate. It is available only for approved Shield configurations. It requires intake review, QuotaGuard approval, signed documentation, and the annual HIPAA / BAA administration add-on.

The add-on covers the administrative work around intake review, BAA record preparation and maintenance, annual configuration review, and related security and compliance administration.

See the current Shield pricing at quotaguard.com/products/pricing.

Data Residency Is Reviewed by Configuration

Some healthcare organizations have specific data residency requirements. For those customers, QuotaGuard can discuss approved configurations designed to keep covered Shield routing and applicable operational metadata within selected regions.

These arrangements are reviewed case by case. They should be confirmed in the applicable Shield configuration, order form, or BAA-related documentation.

A Typical Healthcare API Setup Uses Shield for Vendor Allowlisting

A health technology company on Heroku builds a patient portal that calls an EHR API. The EHR vendor requires IP allowlisting. Heroku does not provide stable outbound static IPs for the app by default.

The team could use a standard proxy to get static IPs. That may work technically. During vendor review, the security team may ask whether the proxy decrypts traffic and whether BAA coverage is available.

With QuotaGuard Shield, the customer can route outbound traffic through static proxy IPs while keeping customer payload contents from being decrypted at the proxy in ordinary operation. If the use case requires BAA coverage, the customer completes QuotaGuard’s HIPAA / BAA intake process before sending production ePHI through the service.

Testing Shield Starts With Confirming the Outbound IP

After configuring Shield, customers can verify the outbound IP and the result shows the static IP the destination service will see.

The customer then submits the assigned Shield IPs to the EHR, lab, pharmacy, or healthcare API vendor for allowlisting.

Region is selected at signup. Changing regions later requires contacting support. Customers should choose the region closest to the destination API or the region required by their internal compliance review.

A Static IP Proxy Is Only One Part of HIPAA Architecture

Shield does not make an entire application HIPAA compliant by itself.

Customers still need appropriate application security, database security, access controls, logging, incident response procedures, policies, training, vendor review, and internal compliance controls.

Shield solves a narrower infrastructure problem. It gives healthcare apps static proxy IPs for vendor allowlisting while supporting encrypted transmission for approved Shield configurations.

Start With Shield, Then Request BAA Review If PHI Is Involved

If the app only needs static IPs for an API allowlist, start with QuotaGuard Shield and test the connection.

If the use case involves ePHI and the customer needs BAA coverage, start the BAA review process before sending production PHI through the service. BAA coverage requires QuotaGuard approval, signed documentation, and the annual HIPAA / BAA administration add-on.

Start a Shield trial or start BAA review.